Al Algorithm Predicts Drug Targets, Leads to Promising Results for Experimental Cancer Treatment
Please find the full article here.
Please find the full article here.
Please find our press release here and Ohara’s press release here.
Please find the full article here.
Isabel Arrillaga-Romany, MD, PhD @MGHNeuroOnc @Oncoceutics explains how this is going to affect clinicians today and what clinicians should know about patients with the H3 K27 mutation. Content Warning: These Videos Are Intended for Doctors and Health Care Professionals. What should clinicians know about patients with the H3 K27M mutation? ONC201 in adult recurrent GBM